Mylan Pharmaceuticals Inc recalls Rifampin for Injection, USP, 600 mg/vial, One Vial per carton, Rx only, Manufactured for: Mylan Institutional LLC, Morga
Recalled April 27, 2022 · FDA recall D-0774-2022 · Mylan Pharmaceuticals
Hazard
Failed Impurities/Degradation Specifications: High out of specification results obtained for related compound during stability testing. · FDA Class II
Units
33,893 vials
Sold at
Nationwide in the USA
Description
Failed Impurities/Degradation Specifications: High out of specification results obtained for related compound during stability testing.
Product
Rifampin for Injection, USP, 600 mg/vial, One Vial per carton, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26505 U.S.A., NDC 67457-445-60
Manufacturer(s)
Mylan Pharmaceuticals Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →